JP2009503089A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009503089A5 JP2009503089A5 JP2008525104A JP2008525104A JP2009503089A5 JP 2009503089 A5 JP2009503089 A5 JP 2009503089A5 JP 2008525104 A JP2008525104 A JP 2008525104A JP 2008525104 A JP2008525104 A JP 2008525104A JP 2009503089 A5 JP2009503089 A5 JP 2009503089A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- substituted
- aryl
- heterocycle
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70534205P | 2005-08-04 | 2005-08-04 | |
| PCT/US2006/029877 WO2007019130A2 (en) | 2005-08-04 | 2006-07-28 | Hiv integrase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009503089A JP2009503089A (ja) | 2009-01-29 |
| JP2009503089A5 true JP2009503089A5 (https=) | 2009-09-03 |
Family
ID=37727857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008525104A Pending JP2009503089A (ja) | 2005-08-04 | 2006-07-28 | Ｈｉｖインテグラーゼ阻害薬 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20080234231A1 (https=) |
| EP (1) | EP1909578A4 (https=) |
| JP (1) | JP2009503089A (https=) |
| WO (1) | WO2007019130A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8283366B2 (en) | 2010-01-22 | 2012-10-09 | Ambrilia Biopharma, Inc. | Derivatives of pyridoxine for inhibiting HIV integrase |
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6225318B1 (en) * | 1996-10-17 | 2001-05-01 | Pfizer Inc | 4-aminoquinazolone derivatives |
| EP1326611B1 (en) * | 2000-10-12 | 2007-06-13 | Merck & Co., Inc. | Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors |
| PL360944A1 (en) * | 2000-10-12 | 2004-09-20 | Merck & Co, Inc. | Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| EP1467970B1 (en) * | 2002-01-17 | 2007-08-22 | Merck & Co., Inc. | Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors |
| ATE404537T1 (de) * | 2002-08-13 | 2008-08-15 | Shionogi & Co | Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung |
| WO2004035577A2 (en) * | 2002-10-16 | 2004-04-29 | Gilead Sciences, Inc. | Pre-organized tricyclic integrase inhibitor compounds |
| TW200505902A (en) * | 2003-03-20 | 2005-02-16 | Schering Corp | Cannabinoid receptor ligands |
| CA2537325A1 (en) * | 2003-09-19 | 2005-03-31 | Gilead Sciences, Inc. | Aza-quinolinol phosphonate integrase inhibitor compounds |
| CN1976915A (zh) * | 2004-02-11 | 2007-06-06 | 史密丝克莱恩比彻姆公司 | Hiv整合酶抑制剂 |
-
2006
- 2006-07-28 EP EP06789073A patent/EP1909578A4/en not_active Withdrawn
- 2006-07-28 JP JP2008525104A patent/JP2009503089A/ja active Pending
- 2006-07-28 WO PCT/US2006/029877 patent/WO2007019130A2/en not_active Ceased
- 2006-07-28 US US11/997,795 patent/US20080234231A1/en not_active Abandoned